Alger Small Cap Fund Outperforms Index in Fourth Quarter 2025
Fred Alger Management's Small Cap Focus Fund outperformed the Russell 2000 Growth Index in Q4 2025, with Guardant Health highlighted as a key holding after strong quarterly results.
Topic
Latest reporting and analysis tagged with Guardant Health.
Fred Alger Management's Small Cap Focus Fund outperformed the Russell 2000 Growth Index in Q4 2025, with Guardant Health highlighted as a key holding after strong quarterly results.
Stifel and Mizuho increased price targets for Guardant Health on January 9, citing anticipated growth in 2026. The company is a precision oncology firm known for liquid biopsy tests.